Join our Chief Product Officer, Eric Malis for another in-depth webinar on Nitazines, a potent and emerging class of synthetic opioids. We’ll explore current trends in Nitazine usage, the challenges in detecting and testing for these substances, and the latest screening methods, as well as, the significant threat they pose to public health. This session is crucial for healthcare professionals and policymakers to understand the growing impact of Nitazines and develop effective strategies to address the rise in use.
